Xcellerant Ventures
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Jetstream
  • Contact
Select Page
Scottsdale’s Xcellerant Ventures Launches Jetstream Venture Fund, Expanding Access to VC-Style Investing

Scottsdale’s Xcellerant Ventures Launches Jetstream Venture Fund, Expanding Access to VC-Style Investing

by Xcellerant Ventures | Oct 9, 2025 | Xcellerant Ventures News

SCOTTSDALE, Ariz., Oct. 9, 2025 /PRNewswire/ — Xcellerant Ventures (XVC) today announced the launch of the Jetstream Venture Fund (Jetstream), an innovative interval fund recently declared effective by the SEC. Jetstream seeks to provide...
Xcellerant Ventures Invests in Mindset Medical to Advance Contactless Vital Sign Monitoring

Xcellerant Ventures Invests in Mindset Medical to Advance Contactless Vital Sign Monitoring

by Xcellerant Ventures | Oct 7, 2025 | Portfolio Company News, Xcellerant Ventures News

SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Xcellerant Ventures (XVC) is proud to announce its investment in Mindset Medical (Mindset), a Phoenix-based digital health company pioneering software-only, contactless vital sign monitoring. This investment marks the...
Xcellerant Ventures Leads DeepLook Medical’s Series A Round

Xcellerant Ventures Leads DeepLook Medical’s Series A Round

by Xcellerant Ventures | Sep 24, 2024 | Portfolio Company News, Xcellerant Ventures News

Origionally posted on Business Wire: https://www.businesswire.com/news/home/20240924360690/en/Xcellerant-Ventures-Leads-DeepLook-Medical%E2%80%99s-Series-A-Round   SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Xcellerant Ventures is proud to announce that it will lead...
Why We Invested: CRISPR QC

Why We Invested: CRISPR QC

by Xcellerant Ventures | Jan 12, 2024 | Portfolio Company News, Xcellerant Ventures News

Why Xcellerant Ventures Invested in CRISPR QC The Xcellerant Venture’s team is proud to lead a Series A funding round for CRISPR QC, the San Diego-based biotechnology company that has developed the world’s first and only CRISPR Analytics Platform.  This platform...
Xcellerant Ventures Ends First Year with 10th Investment, Leading CRISPR QC’s $10 Million Series A Round

Xcellerant Ventures Ends First Year with 10th Investment, Leading CRISPR QC’s $10 Million Series A Round

by Xcellerant Ventures | Jan 6, 2024 | Xcellerant Ventures News

Origionally posted on Business Wire: https://www.businesswire.com/news/home/20240105587000/en/Xcellerant-Ventures-Ends-First-Year-with-10th-Investment-Leading-CRISPR-QC%E2%80%99s-10-Million-Series-A-Round SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Xcellerant...
Why We Invested: Lenoss Medical

Why We Invested: Lenoss Medical

by Xcellerant Ventures | Dec 20, 2023 | Portfolio Company News, Xcellerant Ventures News

Why Xcellerant Ventures Invested in Lenoss Medical The Xcellerant Venture’s team proudly welcomes Lenoss Medical as our 9th portfolio company in Xcellerant Ventures Fund 1. The enthusiasm surrounding their groundbreaking technology is nothing short of exhilarating. In...
« Older Entries

Recent Posts

  • Democratizing health care: There’s an app for that
  • Nanodropper® Now Operating as Mu Medical™, Planned Expansion of Precision Eyecare Platform with Bedo Solutions and Viseon Labs
  • DeepLook Medical Expands Precision Imaging Capabilities Through Strategic Partnerships and Expert Advisors, Integrating Innovative Solutions into Widely Used Platforms to Deliver Critical Insights at
  • DeepLook Medical and NHS Oxford University UK announce new study
  • Scottsdale’s Xcellerant Ventures Launches Jetstream Venture Fund, Expanding Access to VC-Style Investing

Recent Comments

No comments to show.
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Contact
  • Privacy Policy
© Xcellerant Ventures 2023